![Alison Lawton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Lawton
Chairman at
DIANTHUS THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
Alison Francis Lawton is currently Director at AgBiome INC since 2021, Director at SwanBio Therapeutics, Inc. since 2021, Independent Director at Dianthus Therapeutics, Inc. since 2023, Director at Bluerock Therapeutics, Inc., and President at Cadena Bio, Inc. Former roles include Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC from 2012 to 2014, Director at CoLucid Pharmaceuticals, Inc. from 2016 to 2017, Independent Director at Spyre Therapeutics, Inc. from 2020 to 2024, Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc. from 2012 to 2020, Director at Kaleido Biosciences, Inc. in 2020, Director at Magenta Therapeutics, Inc. from 2017 to 2018, Independent Director at Magenta Therapeutics, Inc. from 2020 to 2021, Independent Director at X4 Pharmaceuticals, Inc. from 2020 to 2025, Senior Vice President at Genzyme Corp.
from 2011 to 2012, Chief Operating Officer at Aura Biosciences, Inc. from 2015 to 2017, Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp.
from 2012 to 2013, General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc. from 2013 to 2014, Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc. from 2014 to 2017, Senior Vice President & General Manager at BIOSURGERY S.R.L., and Independent Member-Supervisory Board at ProQR Therapeutics NV from 2014 to 2026.
Education includes undergraduate studies at King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Alison Lawton active positions
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chairman | 11/09/2023 |
Cadena Bio, Inc.
 Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Manufactures supplements for human health and nutrition by feeding the micro biome | President | - |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology Operates as a biotechnology platform that develops isolated microbes for agriculture industry | Director/Board Member | 04/05/2021 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Director/Board Member | 19/01/2021 |
Bluerock Therapeutics, Inc.
 Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York. | Director/Board Member | - |
Former positions of Alison Lawton
| Companies | Position | End |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director/Board Member | 02/06/2026 |
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 09/06/2025 |
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 01/02/2024 |
| KALEIDO BIOSCIENCES, INC. | Chief Executive Officer | 16/06/2020 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Alison Lawton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Develops and manufactures biotherapeutic and biomaterial products | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Consumer Services |
Massachusetts Medical Device Industry Council
 Massachusetts Medical Device Industry Council Miscellaneous Commercial ServicesCommercial Services Operates council for information on medical devices and other health topics | Commercial Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology Operates as a biotechnology platform that develops isolated microbes for agriculture industry | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Cadena Bio, Inc.
Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Manufactures supplements for human health and nutrition by feeding the micro biome | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Sanofi-Aventis, Inc.
 Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Health Technology |
Bluerock Therapeutics, Inc.
Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York. | |
BIOSURGERY S.R.L.
 BIOSURGERY S.R.L. Medical DistributorsDistribution Services Wholesales medical surgical and ortho medical products | Distribution Services |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Alison Lawton
